CA3029375A1 - Novel processes for preparation of soluble guanylate cyclase stimulators - Google Patents

Novel processes for preparation of soluble guanylate cyclase stimulators Download PDF

Info

Publication number
CA3029375A1
CA3029375A1 CA3029375A CA3029375A CA3029375A1 CA 3029375 A1 CA3029375 A1 CA 3029375A1 CA 3029375 A CA3029375 A CA 3029375A CA 3029375 A CA3029375 A CA 3029375A CA 3029375 A1 CA3029375 A1 CA 3029375A1
Authority
CA
Canada
Prior art keywords
appropriate amount
formula
organic solvent
optionally
suitable temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3029375A
Other languages
English (en)
French (fr)
Inventor
Song Xue
Vishnu Vardhan Reddy Karnati
Robert C. Livingston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclerion Therapeutics Inc
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of CA3029375A1 publication Critical patent/CA3029375A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA3029375A 2016-07-07 2017-07-06 Novel processes for preparation of soluble guanylate cyclase stimulators Pending CA3029375A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662359453P 2016-07-07 2016-07-07
US62/359,453 2016-07-07
PCT/US2017/040810 WO2018009597A1 (en) 2016-07-07 2017-07-06 Novel processes for preparation of soluble guanylate cyclase stimulators

Publications (1)

Publication Number Publication Date
CA3029375A1 true CA3029375A1 (en) 2018-01-11

Family

ID=59416789

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3029375A Pending CA3029375A1 (en) 2016-07-07 2017-07-06 Novel processes for preparation of soluble guanylate cyclase stimulators

Country Status (16)

Country Link
US (4) US11319308B2 (https=)
EP (2) EP3481818B1 (https=)
JP (1) JP7112384B2 (https=)
KR (1) KR102487872B1 (https=)
CN (2) CN109563077B (https=)
AU (1) AU2017291827B2 (https=)
BR (1) BR112019000291A2 (https=)
CA (1) CA3029375A1 (https=)
CL (2) CL2019000016A1 (https=)
EA (1) EA201990237A1 (https=)
ES (1) ES2963563T3 (https=)
IL (1) IL263995B (https=)
MA (1) MA45603A (https=)
MX (2) MX389920B (https=)
SG (1) SG11201900096QA (https=)
WO (1) WO2018009597A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109563077B (zh) 2016-07-07 2026-03-10 赛克里翁治疗有限公司 用于制备可溶性鸟苷酸环化酶刺激剂的新方法
WO2018009602A2 (en) * 2016-07-07 2018-01-11 Ironwood Pharmaceuticals, Inc. Novel processes for preparation of soluble guanylate cyclase stimulators
MA71753A (fr) 2018-01-10 2025-05-30 Cyclerion Therapeutics, Inc. Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble
WO2019161534A1 (en) * 2018-02-22 2019-08-29 Ironwood Pharmaceuticals, Inc. Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ603789A (en) * 2010-05-26 2015-03-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof
AR088020A1 (es) 2010-06-30 2014-05-07 Ironwood Pharmaceuticals Inc Compuestos heterociclicos como estimuladores de sgc
CN106117194A (zh) 2011-12-27 2016-11-16 铁木医药有限公司 可用作sgc刺激剂的2‑苄基、3‑(嘧啶‑2‑基)取代的吡唑类
US9487508B2 (en) * 2012-09-19 2016-11-08 Ironwood Pharmaceuticals, Inc. SGC stimulators
SI2970243T1 (sl) * 2013-03-15 2020-04-30 Cyclerion Therapeutics, Inc. SGC stimulatorji
JP2016540017A (ja) * 2013-12-11 2016-12-22 アイアンウッド ファーマシューティカルズ インコーポレイテッド sGC刺激物質
US20170291889A1 (en) * 2014-09-17 2017-10-12 Ironwood Pharmaceuticals, Inc. Pyrazole derivatives as sgc stimulators
EP3194386A2 (en) * 2014-09-17 2017-07-26 Ironwood Pharmaceuticals, Inc. Sgc stimulators
US20170298055A1 (en) * 2014-09-17 2017-10-19 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
KR20170055531A (ko) * 2014-09-17 2017-05-19 아이언우드 파마슈티컬스, 인코포레이티드 에스지씨 자극제
CA3006746C (en) * 2015-11-30 2024-01-30 Ironwood Pharmaceuticals, Inc. Solid dispersions comprising a sgc stimulator
WO2018009602A2 (en) 2016-07-07 2018-01-11 Ironwood Pharmaceuticals, Inc. Novel processes for preparation of soluble guanylate cyclase stimulators
MX389964B (es) * 2016-07-07 2025-03-19 Cyclerion Therapeutics Inc Formas sólidas de un estimulador de guanilato ciclasa soluble (sgc).
CN109563077B (zh) 2016-07-07 2026-03-10 赛克里翁治疗有限公司 用于制备可溶性鸟苷酸环化酶刺激剂的新方法
CA3086207A1 (en) * 2017-12-19 2019-06-27 Cyclerion Therapeutics, Inc. Sgc stimulators
MA71753A (fr) * 2018-01-10 2025-05-30 Cyclerion Therapeutics, Inc. Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble

Also Published As

Publication number Publication date
BR112019000291A2 (pt) 2019-04-16
KR102487872B1 (ko) 2023-01-12
EP4249488A2 (en) 2023-09-27
EP3481818A1 (en) 2019-05-15
IL263995A (en) 2019-02-28
MX2019000105A (es) 2019-04-22
US20260103457A1 (en) 2026-04-16
NZ750123A (en) 2025-02-28
CL2023000228A1 (es) 2023-09-29
EP3481818C0 (en) 2023-09-06
EP4249488A3 (en) 2023-12-20
MA45603A (fr) 2019-05-15
AU2017291827A1 (en) 2019-02-07
US20240059684A1 (en) 2024-02-22
EA201990237A1 (ru) 2019-08-30
CL2019000016A1 (es) 2019-05-03
AU2017291827B2 (en) 2021-10-21
US20210323951A1 (en) 2021-10-21
CN109563077B (zh) 2026-03-10
SG11201900096QA (en) 2019-02-27
MX389920B (es) 2025-03-20
WO2018009597A1 (en) 2018-01-11
CN109563077A (zh) 2019-04-02
KR20190025986A (ko) 2019-03-12
CN121673266A (zh) 2026-03-17
JP2019525913A (ja) 2019-09-12
MX2022001495A (es) 2022-03-11
ES2963563T3 (es) 2024-03-27
US11319308B2 (en) 2022-05-03
JP7112384B2 (ja) 2022-08-03
IL263995B (en) 2021-02-28
US20220227748A1 (en) 2022-07-21
EP3481818B1 (en) 2023-09-06
US11773089B2 (en) 2023-10-03

Similar Documents

Publication Publication Date Title
US11773089B2 (en) Process for preparation of soluble guanylate cyclase stimulators
US12247025B2 (en) Processes for preparation of soluble guanylate cyclase stimulators
EP4121029A1 (en) Benzenesulfonamide derivatives as trap1 modulators and uses thereof
HK40103206A (en) Novel processes for preparation of soluble guanylate cyclase stimulators
HK40007031B (en) Novel processes for preparation of soluble guanylate cyclase stimulators
HK40007031A (en) Novel processes for preparation of soluble guanylate cyclase stimulators
HK40007032B (en) Novel processes for preparation of soluble guanylate cyclase stimulators
HK40007032A (en) Novel processes for preparation of soluble guanylate cyclase stimulators
OA19467A (en) Novel processes for preparation of soluble Guanylate Cyclase stimulators.
OA19466A (en) Novel processes for preparation of soluble Guanylate Cyclase stimulators.
EA047613B1 (ru) Новые способы получения стимуляторов растворимой гуанилатциклазы
EA041479B1 (ru) Новые способы получения промежуточных соединений для синтеза стимуляторов растворимой гуанилатциклазы
EA040047B1 (ru) Новые способы получения стимуляторов растворимой гуанилатциклазы

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220705

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20240821

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250106

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250422

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250422

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250627

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250627

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250811

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250811

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D164 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: RESPONSE TO NOTICE OF ALLOWANCE

Effective date: 20251210

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-4-D10-D22-D143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRE-GRANT

Effective date: 20260312

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260312